Growth Metrics

Pfizer (PFE) Enterprise Value Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 24.95%
Dec 31, 2025 34.12%
Sep 28, 2025 -51.75%
Jun 29, 2025 -89.48%
Mar 30, 2025 -46.05%
Dec 31, 2024 -62.56%
Sep 29, 2024 77.96%
Jun 30, 2024 84.67%
Mar 31, 2024 40.87%
Dec 31, 2023 44.76%
Oct 1, 2023 -22.33%
Jul 2, 2023 -34.71%
Apr 2, 2023 16.63%
Dec 31, 2022 27.04%
Oct 2, 2022 -22.02%
Jul 3, 2022 -54.21%
Apr 3, 2022 -76.10%
Dec 31, 2021 -156.98%
Oct 3, 2021 -130.63%
Jul 4, 2021 5.05%
Apr 4, 2021 -33.71%
Dec 31, 2020 -28.31%
Sep 27, 2020 -42.01%
Jun 28, 2020 -79.74%
Mar 29, 2020 10.91%
Dec 31, 2019 49.45%
Sep 29, 2019 46.83%
Jun 30, 2019 -405.23%
Mar 31, 2019 -279.23%
Dec 31, 2018 6.34%
Sep 30, 2018 -87.97%
Jul 1, 2018 47.45%
Apr 1, 2018 34.28%
Dec 31, 2017 -11.96%
Oct 1, 2017 36.16%
Jul 2, 2017 77.09%
Apr 2, 2017 76.41%
Dec 31, 2016 23.63%
Oct 2, 2016 30.90%
Jul 3, 2016 31.11%
Apr 3, 2016 30.12%
Dec 31, 2015 35.54%
Sep 27, 2015 38.51%
Jun 28, 2015 11.15%
Mar 29, 2015 18.33%
Dec 31, 2014 -11.55%
Sep 28, 2014 0.50%
Jun 29, 2014 -1.35%
Mar 30, 2014 2.74%
Dec 31, 2013 -0.36%
Sep 29, 2013 -47.61%
Jun 30, 2013 -39.30%
Mar 31, 2013 -46.61%
Dec 31, 2012 -22.90%
Sep 30, 2012 20.80%
Jul 1, 2012 4.44%
Apr 1, 2012 -0.03%
Dec 31, 2011 5.58%
Oct 2, 2011 -29.27%
Jul 3, 2011 -32.78%
Apr 3, 2011 -39.81%
Dec 31, 2010 -7.92%
Oct 3, 2010 57.94%
Jul 4, 2010 61.93%
Apr 4, 2010 -1,250.36%